US Patent Issued to Regeneron Pharmaceuticals on Feb. 28 for "Dosing strategy that mitigates cytokine release syndrome for therapeutic antibodies" (New York, New Jersey Inventors)

  • Israel Lowy,

Press/Media

Period1 Mar 2023

Media coverage

1

Media coverage

  • TitleUS Patent Issued to Regeneron Pharmaceuticals on Feb. 28 for "Dosing strategy that mitigates cytokine release syndrome for therapeutic antibodies" (New York, New Jersey Inventors)
    Media name/outletUS Fed News
    Country/TerritoryUnited States
    Date1/03/23
    URLct.moreover.com/?a=50136381216&p=1gw&v=1&x=nsDlfCX5bGQIElFphDlZdw
    PersonsIsrael Lowy,
View all 1
View less